[Controlled clinical evaluation of the therapeutic activity of 3 antiulcer agents in peptic ulcer: carbenoxolone, proglumide and zolimidine].
D000368:Aged; D002229:Carbenoxolone / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D005973:Glutamine / Q000031:analogs & derivatives*; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy*; D011377:Proglumide / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D011897:Random Allocation
D011725:Pyridines; D005973:Glutamine; D011377:Proglumide; D002229:Carbenoxolone; D006034:Glycyrrhetinic Acid
Valutazione clinica controllata dell'attività terapeutica, nell'ulcera peptica, di tre farmaci antiulcerosi: sodio carbenoxolone, proglumide e zolimidina.